Modular and Automated Synthesis of Oligonucleotide-Small Molecule Conjugates for Cathepsin B Mediated Traceless Release of Payloads

12 January 2024, Version 1
This content is a preprint and has not undergone peer review at the time of posting.

Abstract

Attachment of small molecules to oligonucleotides is a versatile tool in the development of therapeutic oligonucleotides. However, cleavable linkers in the oligonucleotide field are scarce, particularly with respect to the requirement of traceless release of payload in vivo. Herein, a cathepsin B-cleavable dipeptide phosphoramidite, Val-Ala(NB), is developed for the automated synthesis of oligonucleotide-small molecule conjugates. Val-Ala(NB) was protected by photolabile 2-nitrobenzyl to improve stability of the peptide linker during DNA synthesis. After photolysis, intracellular cathepsin B digests the dipeptide efficiently, releasing the payload-phosphate which is converted to the free payload by endogenous phosphatase enzymes. With the advantages of modular synthesis and stimuli-responsive drug release, we believe Val-Ala(NB) will be a commonly used cleavable linker in the development of oligonucleotide-drug conjugates.

Keywords

cleavable linker
cathepsin B
oligonucleotide drug conjugate

Comments

Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.